VEGFR2/CD309 antibody (AA 31-130)

Catalog No. ABIN517318

This Mouse Monoclonal antibody specifically detects VEGFR2/CD309 in WB and ELISA. It exhibits reactivity toward Human.

Quick Overview for VEGFR2/CD309 antibody (AA 31-130) (ABIN517318)

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This VEGFR2/CD309 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Clone: 2A2

Product Details anti-VEGFR2/CD309 Antibody

Binding Specificity: AA 31-130

Purpose: Mouse monoclonal antibody raised against a partial recombinant KDR.

Sequence: LPRLSIQKDI LTIKANTTLQ ITCRGQRDLD WLWPNNQSGS EQRVEVTECS DGLFCKTLTI PKVIGNDTGA YKCFYRETDL ASVIYVYVQD YRSPFIASVS

Cross-Reactivity: Human

Characteristics: Antibody Reactive Against Recombinant Protein.

Immunogen: KDR (NP_002244, 31 a.a. ~ 130 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Isotype: IgG2a

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: In 1x PBS, pH 7.4

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Target Details for VEGFR2/CD309

Target: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Alternative Name: KDR

Background: Full Gene Name: kinase insert domain receptor (a type III receptor tyrosine kinase)
Synonyms: CD309,FLK1,VEGFR,VEGFR2

Gene ID: 3791

NCBI Accession: NM_002253

Pathways: RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling